X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4397) 4397
Newspaper Article (812) 812
Newsletter (397) 397
Magazine Article (64) 64
Trade Publication Article (23) 23
Book Chapter (12) 12
Dissertation (5) 5
Web Resource (3) 3
Book Review (2) 2
Paper (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
multiple sclerosis (3636) 3636
humans (3000) 3000
interferon (2053) 2053
interferon beta-1a (1993) 1993
clinical neurology (1653) 1653
female (1543) 1543
male (1413) 1413
adult (1404) 1404
interferon-beta - therapeutic use (1304) 1304
multiple sclerosis - drug therapy (1123) 1123
interferon beta (1033) 1033
middle aged (956) 956
neurosciences (925) 925
biological response modifiers (834) 834
double-blind (804) 804
multiple sclerosis, relapsing-remitting - drug therapy (796) 796
interferon beta-1b (786) 786
neurology (767) 767
treatment outcome (743) 743
glatiramer acetate (655) 655
magnetic resonance imaging (639) 639
care and treatment (586) 586
drug therapy (563) 563
adjuvants, immunologic - therapeutic use (550) 550
research (550) 550
clinical trials (531) 531
patients (512) 512
interferon-beta (489) 489
disease progression (486) 486
placebo-controlled trial (471) 471
interferon-beta - administration & dosage (467) 467
disability (451) 451
therapy (449) 449
interferon-beta - adverse effects (405) 405
pharmacology & pharmacy (404) 404
immunologic factors - therapeutic use (391) 391
immunology (383) 383
disease (371) 371
multicenter (367) 367
studies (365) 365
adolescent (361) 361
immunosuppressive agents - therapeutic use (342) 342
natalizumab (334) 334
medicine & public health (330) 330
multiple sclerosis - immunology (329) 329
medical research (317) 317
multiple sclerosis - therapy (305) 305
disability evaluation (300) 300
pharmaceutical industry (293) 293
animals (289) 289
medicine, general & internal (287) 287
recurrence (287) 287
young adult (286) 286
multiple-sclerosis (283) 283
health aspects (274) 274
mri (265) 265
psychiatry (257) 257
time factors (257) 257
adjuvants, immunologic - administration & dosage (256) 256
follow-up studies (256) 256
multiple sclerosis - diagnosis (256) 256
viral antigens (245) 245
medicine, experimental (240) 240
analysis (239) 239
peptides - therapeutic use (234) 234
multiple sclerosis - pathology (232) 232
neutralizing antibodies (231) 231
interferon-beta - pharmacology (227) 227
brain - pathology (224) 224
efficacy (221) 221
medicine (216) 216
adjuvants, immunologic - adverse effects (210) 210
multiple sclerosis - physiopathology (205) 205
clinical trials as topic (204) 204
double-blind method (204) 204
aged (203) 203
nuclear magnetic resonance--nmr (202) 202
inflammation (199) 199
fingolimod (198) 198
dosage and administration (195) 195
follow-up (194) 194
development and progression (193) 193
cytokines (192) 192
interferon-beta - immunology (188) 188
prospective studies (187) 187
retrospective studies (187) 187
diagnostic-criteria (183) 183
drug dosages (183) 183
trial (182) 182
research article (180) 180
risk factors (180) 180
drugs (175) 175
dose-response relationship, drug (174) 174
autoimmune diseases (173) 173
injections, subcutaneous (171) 171
diagnosis (170) 170
natural-history (170) 170
multiple sclerosis, relapsing-remitting - immunology (166) 166
review (164) 164
drug administration schedule (161) 161
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5509) 5509
German (89) 89
French (47) 47
Spanish (38) 38
Russian (37) 37
Portuguese (16) 16
Japanese (11) 11
Polish (11) 11
Czech (10) 10
Hungarian (8) 8
Chinese (4) 4
Italian (3) 3
Croatian (2) 2
Turkish (2) 2
Dutch (1) 1
Icelandic (1) 1
Korean (1) 1
Persian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 3, pp. 221 - 234
Journal Article
Journal Article
by Panitch, H and Anaissie, E and Cines, D and DeGroot, L and Dorsey, F and Phillips, T and Simon, J and Brinar, V and Demarin, V and Janculjak, D and Rudez, J and Vladic, A and Czlonkowska, A and Mirowska-Guzel, D and Kozubski, W and Kwiecinski, H and Stelmasiak, Z and Szczudlik, A and Boyko, A and Gusev, EI and Skoromets, A and Stolyarov, I and Yakhno, N and Zavalishin, I and Shawcross, J and Jones, J and Cox, A.L and Bass, A and Wenzel, D and Biton, V and Cascione, M and Cleeremans, B and Cooper, J and Coyle, P.K and Madigan, D and Cutler, B and Fox, E.J and Mayer, L and Tyer, R and Gazda, S and Glyman, S and Gupta, A and Harney, J and Hutton, G and Jacobs, D and Khan, O and Lisak, R and Tselis, A and Klapper, J and Liss, J and Meyer, D and Rae-Grant, A and Rossman, H and Boudouris, W and Belkin, M and Pierce, R and Royal, W and Shubin, R and Sider, D and Stein, M and Steingo, B and Sullivan, H and Twyman, C and Webb, R and Weinshenker, B and Keegan, B.M and Rauchwarter, D and Wingerchuk, D and Carter, J and Wray, S and Wynn, D and Allen, N and Nagar, C and O'Brien, D and Paskavitz, J and Schaefer, P and Valente, W and Beardsley, D and Bussel, J and Goldberg, M and MacMillan, R and Scadden, D and D'Agostino, R.B and Pencina, M and Gonzales, G and Waldmann, H and Hale, G and Coles, Alasdair J and Compston, D. Alastair S and Selmaj, Krzysztof W and Lake, Stephen L and Moran, Susan and Margolin, David H and Norris, Kim and Tandon, P.K and unav and The CAMMS223 Trial Investigators and CAMMS223 Trial Investigators
The New England journal of medicine, ISSN 1533-4406, 2008, Volume 359, Issue 17, pp. 1786 - 1801
Journal Article
Lancet neurology, ISSN 1474-4422, 2014, Volume 13, Issue 7, pp. 657 - 665
Summary Background Subcutaneous pegylated interferon (peginterferon) beta-1a is being developed for treatment of relapsing multiple sclerosis, with less frequent dosing than currently available first-line injectable treatments... 
Neurology | DRUG | MULTICENTER | EFFICACY | DISABILITY | DISEASE-MODIFYING THERAPIES | ADHERENCE | CLINICAL NEUROLOGY | DEGENERATION | DELIVERY | Clinical trials | Multiple sclerosis | Biological response modifiers | Viral antigens | Interferon beta | Pain | Influenza | Interferon | Infections | Drug therapy | Drug dosages | Engineering Sciences
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2006, Volume 354, Issue 9, pp. 911 - 923
Journal Article
Journal of neuroimmunology, ISSN 0165-5728, 2007, Volume 182, Issue 1, pp. 204 - 211
Journal Article
Lancet neurology, ISSN 1474-4422, 2008, Volume 7, Issue 10, pp. 903 - 914
Journal Article